Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Final analysis of a multicentre, open-label, single-arm, phase 2 trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.06.012 ◽

2020 ◽

Vol 159 ◽

pp. 6-7

Author(s):

V. Makker ◽

D. Rasco ◽

N. Vogelzang ◽

M. Brose ◽

A. Cohn ◽

...

Keyword(s):

Endometrial Cancer ◽

Final Analysis ◽

Phase 2 ◽

Download Full-text

Faculty Opinions recommendation of Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735415442.793560792 ◽

2019 ◽

Author(s):

Steve Plaxe

Keyword(s):

Endometrial Cancer ◽

Interim Analysis ◽

Phase 2 ◽

Download Full-text

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30020-8 ◽

2019 ◽

Vol 20 (5) ◽

pp. 711-718 ◽

Author(s):

Vicky Makker ◽

Drew Rasco ◽

Nicholas J Vogelzang ◽

Marcia S Brose ◽

Allen L Cohn ◽

...

Keyword(s):

Endometrial Cancer ◽

Interim Analysis ◽

Phase 2 ◽

Download Full-text

Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis

European Journal of Cancer ◽

10.1016/j.ejca.2016.08.004 ◽

2016 ◽

Vol 69 ◽

pp. 226-235 ◽

Author(s):

Bernard Escudier ◽

Vincent Molinie ◽

Sergio Bracarda ◽

Pablo Maroto ◽

Cezary Szczylik ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Final Analysis ◽

Phase 2 ◽

Phase 2 Trial ◽

Open Label Phase

Download Full-text

Faculty Opinions recommendation of Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954976.793462183 ◽

2012 ◽

Author(s):

Mark Faries

Keyword(s):

Advanced Melanoma ◽

Phase 2 ◽

Download Full-text

Faculty Opinions recommendation of Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020296.793478787 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C ◽

Phase 2 ◽

Hepatitis C Infection ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Treatment Naïve ◽

Peginterferon Alfa ◽

Download Full-text

Faculty Opinions recommendation of Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726172820.793515335 ◽

2016 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Liver Disease ◽

Hepatitis C ◽

Virus Infection ◽

Phase 2 ◽

Hepatitis C Virus Infection ◽

Advanced Liver Disease ◽

Download Full-text

Dose-Adjusted EPOCH Regimen as First-Line Treatment for Non-Hodgkin's Lymphoma with Hemophagocytic Lymphohistiocytosis: A Single-Arm, Open-Label, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3304299 ◽

2018 ◽

Author(s):

Jin-Hua Liang ◽

Li Wang ◽

Hua-Yuan Zhu ◽

Jun Qian ◽

Hui Liao ◽

...

Keyword(s):

Hemophagocytic Lymphohistiocytosis ◽

Hodgkin's Lymphoma ◽

Line Treatment ◽

Phase 2 ◽

Phase 2 Trial ◽

Non Hodgkin's Lymphoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3487801 ◽

2019 ◽

Author(s):

Lei Gao ◽

Yanqi Zhang ◽

Sanbin Wang ◽

Peiyan Kong ◽

Yi Su ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase 2 ◽

Hematopoietic Stem ◽

Randomized Controlled ◽

Phase 2 Trial ◽

Download Full-text

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3487826 ◽

2019 ◽

Author(s):

Lei Gao ◽

Yanqi Zhang ◽

Sanbin Wang ◽

Peiyan Kong ◽

Yi Su ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase 2 ◽

Hematopoietic Stem ◽

Randomized Controlled ◽

Phase 2 Trial ◽

Download Full-text

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30362-3 ◽

2021 ◽

Author(s):

Cornedine J de Gooijer ◽

Vincent van der Noort ◽

Jos A Stigt ◽

Paul Baas ◽

Bonne Biesma ◽

...

Keyword(s):

Malignant Mesothelioma ◽

Phase 2 ◽

Phase 2 Trial ◽

Open Label Phase ◽

Line Chemotherapy

Download Full-text